Detalles de la búsqueda
1.
5-year follow-up results of a JCOG1104 (OPAS-1) phase III non-inferiority trial to compare 4 courses and 8 courses of S-1 adjuvant chemotherapy for pathological stage II gastric cancer.
Gastric Cancer
; 27(1): 155-163, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37989806
2.
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis.
Int J Clin Oncol
; 29(4): 407-416, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38430303
3.
Incidence and risk factors for venous thromboembolism in the Cancer-VTE Registry stomach cancer subcohort.
Gastric Cancer
; 26(4): 493-503, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37004667
4.
Identifying Risk Factors of Complications following Total Gastrectomy for Gastric Cancer: Comparison between Splenectomy and Spleen-Preserving Surgery - A Supplementary Analysis of JCOG0110.
Dig Surg
; 40(3-4): 114-120, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459840
5.
Five-year follow-up of a randomized clinical trial comparing bursectomy and omentectomy alone for resectable gastric cancer (JCOG1001).
Br J Surg
; 110(1): 50-56, 2022 12 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369984
6.
The Amount and Concentration of Drain Amylase Together Predict Postoperative Pancreatic Fistula after Gastric Cancer Surgery More Accurately than the Concentration Alone.
Oncology
; 100(7): 363-369, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35340009
7.
Negative impact of intraoperative blood loss on long-term outcome after curative gastrectomy for advanced gastric cancer: exploratory analysis of the JCOG1001 phase III trial.
Gastric Cancer
; 25(2): 459-467, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797440
8.
Impact of tumor-related factors and inter-institutional heterogeneity on preoperative T staging for gastric cancer.
Future Oncol
; 18(20): 2511-2519, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35582901
9.
Association of renal function with the safety and efficacy of cisplatin plus S-1 therapy and docetaxel plus cisplatin plus S-1 therapy in patients with advanced gastric cancer: an exploratory analysis of JCOG1013.
Jpn J Clin Oncol
; 52(1): 14-23, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34668562
10.
Is the ISGPS definition of pancreatic fistula applicable after gastrectomy?
Int J Clin Oncol
; 27(8): 1273-1278, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35570258
11.
Posttherapy topographical nodal status, ypN-site, predicts survival of patients who received neoadjuvant chemotherapy followed by curative surgical resection for non-type 4 locally advanced gastric cancer: supplementary analysis of JCOG1004-A.
Gastric Cancer
; 24(1): 197-204, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-32572792
12.
Gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer (JCOG0501): an open-label, phase 3, randomized controlled trial.
Gastric Cancer
; 24(2): 492-502, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33200303
13.
Determinant Factors on Differences in Survival for Gastric Cancer Between the United States and Japan Using Nationwide Databases.
J Epidemiol
; 31(4): 241-248, 2021 04 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32281553
14.
The Combined Use of Drainage Amylase Concentration and Serum C-reactive Protein as Predictors of Pancreas-Related Complications after Elective Gastrectomy.
Oncology
; 98(2): 111-116, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31600759
15.
Long-term outcomes of preoperative docetaxel with cisplatin plus S-1 therapy for gastric cancer with extensive nodal metastasis (JCOG1002).
Gastric Cancer
; 23(2): 293-299, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31515693
16.
Current status of perioperative chemotherapy for locally advanced gastric cancer and JCOG perspectives.
Jpn J Clin Oncol
; 50(5): 528-534, 2020 May 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32134452
17.
Venous thromboembolism in cancer patients: report of baseline data from the multicentre, prospective Cancer-VTE Registry.
Jpn J Clin Oncol
; 50(11): 1246-1253, 2020 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-32715307
18.
Survival Outcomes of Two Phase 2 Studies of Adjuvant Chemotherapy with S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Patients with Gastric Cancer After D2 Gastrectomy.
Ann Surg Oncol
; 26(2): 465-472, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30456678
19.
An integrated analysis of two phase II trials (JCOG0001 and JCOG0405) of preoperative chemotherapy followed by D3 gastrectomy for gastric cancer with extensive lymph node metastasis.
Gastric Cancer
; 22(6): 1301-1307, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31264058
20.
Randomized phase III trial of gastrectomy with or without neoadjuvant S-1 plus cisplatin for type 4 or large type 3 gastric cancer, the short-term safety and surgical results: Japan Clinical Oncology Group Study (JCOG0501).
Gastric Cancer
; 22(5): 1044-1052, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30827001